

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0000664"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0000664" />

    <meta name="citation_title" content="HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis"/>
    <meta itemprop="name" content="HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis"/>

      <meta name="citation_author" content="Boel Brynedal"/>
            <meta name="citation_author_institution" content="Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"/>
      <meta name="citation_author" content="Kristina Duvefelt"/>
            <meta name="citation_author_institution" content="Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"/>
            <meta name="citation_author_institution" content="Mutation Analysis Facility, Clinical Research Center, Karolinska University Hospital, Stockholm, Sweden"/>
      <meta name="citation_author" content="Gudrun Jonasdottir"/>
            <meta name="citation_author_institution" content="Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"/>
      <meta name="citation_author" content="Izaura M. Roos"/>
            <meta name="citation_author_institution" content="Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"/>
      <meta name="citation_author" content="Eva Åkesson"/>
            <meta name="citation_author_institution" content="Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"/>
      <meta name="citation_author" content="Juni Palmgren"/>
            <meta name="citation_author_institution" content="Mutation Analysis Facility, Clinical Research Center, Karolinska University Hospital, Stockholm, Sweden"/>
      <meta name="citation_author" content="Jan Hillert"/>
            <meta name="citation_author_institution" content="Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"/>

    <meta name="citation_date" content="2007/7/25"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0000664.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e664"/>
    <meta name="citation_issue" content="7"/>
    <meta name="citation_volume" content="2"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Gene map of the extended human MHC.; citation_author=R Horton; citation_author=L Wilming; citation_author=V Rand; citation_author=RC Lovering; citation_author=EA Bruford; citation_journal_title=Nat Rev Genet; citation_volume=5; citation_number=1; citation_pages=889-899; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Histocompatibility (HL-A) antigens associated with multiple sclerosis.; citation_author=C Jersild; citation_author=T Fog; citation_journal_title=Acta Neurol Scand Suppl; citation_volume=51; citation_number=2; citation_pages=377; citation_date=1972; " />
      <meta name="citation_reference" content="citation_title=Human leukocyte antigen studies in multiple sclerosis.; citation_author=J Hillert; citation_journal_title=Ann Neurol; citation_number=3; citation_pages=S15-17; citation_date=1994; " />
      <meta name="citation_reference" content="citation_title=A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis.; citation_author=MR Lincoln; citation_author=A Montpetit; citation_author=MZ Cader; citation_author=J Saarela; citation_author=DA Dyment; citation_journal_title=Nat Genet; citation_volume=37; citation_number=4; citation_pages=1108-1112; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Multiple sclerosis: association with HL-A3.; citation_author=S Naito; citation_author=N Namerow; citation_author=MR Mickey; citation_author=PI Terasaki; citation_journal_title=Tissue Antigens; citation_volume=2; citation_number=5; citation_pages=1-4; citation_date=1972; " />
      <meta name="citation_reference" content="citation_title=Histocompatibility determinants in multiple sclerosis, with special reference to clinical course.; citation_author=C Jersild; citation_author=T Fog; citation_author=GS Hansen; citation_author=M Thomsen; citation_author=A Svejgaard; citation_journal_title=Lancet; citation_volume=2; citation_number=6; citation_pages=1221-1225; citation_date=1973; " />
      <meta name="citation_reference" content="citation_title=Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease.; citation_author=A Fogdell-Hahn; citation_author=A Ligers; citation_author=M Gronning; citation_author=J Hillert; citation_author=O Olerup; citation_journal_title=Tissue Antigens; citation_volume=55; citation_number=7; citation_pages=140-148; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis.; citation_author=HF Harbo; citation_author=BA Lie; citation_author=S Sawcer; citation_author=EG Celius; citation_author=KZ Dai; citation_journal_title=Tissue Antigens; citation_volume=63; citation_number=8; citation_pages=237-247; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=A second major histocompatibility complex susceptibility locus for multiple sclerosis.; citation_author=TW Yeo; citation_author=PL De Jager; citation_author=SG Gregory; citation_author=LF Barcellos; citation_author=A Walton; citation_journal_title=Ann Neurol; citation_number=9; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.; citation_author=DA Dyment; citation_author=BM Herrera; citation_author=MZ Cader; citation_author=CJ Willer; citation_author=MR Lincoln; citation_journal_title=Hum Mol Genet; citation_volume=14; citation_number=10; citation_pages=2019-2026; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.; citation_author=LF Barcellos; citation_author=S Sawcer; citation_author=PP Ramsay; citation_author=SE Baranzini; citation_author=G Thomson; citation_journal_title=Hum Mol Genet; citation_volume=15; citation_number=11; citation_pages=2813-2824; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes.; citation_author=HJ Cordell; citation_author=DG Clayton; citation_journal_title=Am J Hum Genet; citation_volume=70; citation_number=12; citation_pages=124-141; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.; citation_author=WI McDonald; citation_author=A Compston; citation_author=G Edan; citation_author=D Goodkin; citation_author=HP Hartung; citation_journal_title=Ann Neurol; citation_volume=50; citation_number=13; citation_pages=121-127; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.; citation_author=O Olerup; citation_author=H Zetterquist; citation_journal_title=Tissue Antigens; citation_volume=39; citation_number=14; citation_pages=225-235; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=Performing the exact test of Hardy-Weinberg proportion for multiple alleles.; citation_author=SW Guo; citation_author=EA Thompson; citation_journal_title=Biometrics; citation_volume=48; citation_number=15; citation_pages=361-372; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=Modes of action of HLA-DR susceptibility specificities in multiple sclerosis.; citation_author=H Modin; citation_author=W Olsson; citation_author=J Hillert; citation_author=T Masterman; citation_journal_title=Am J Hum Genet; citation_volume=74; citation_number=16; citation_pages=1321-1322; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.; citation_author=LF Barcellos; citation_author=JR Oksenberg; citation_author=AB Begovich; citation_author=ER Martin; citation_author=S Schmidt; citation_journal_title=Am J Hum Genet; citation_volume=72; citation_number=17; citation_pages=710-716; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=A meta-analysis of whole genome linkage screens in multiple sclerosis.; citation_journal_title=J Neuroimmunol; citation_volume=143; citation_number=18; citation_pages=39-46; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=A high-density screen for linkage in multiple sclerosis.; citation_author=S Sawcer; citation_author=M Ban; citation_author=M Maranian; citation_author=TW Yeo; citation_author=A Compston; citation_journal_title=Am J Hum Genet; citation_volume=77; citation_number=19; citation_pages=454-467; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?; citation_author=MA Friese; citation_author=L Fugger; citation_journal_title=Brain; citation_volume=128; citation_number=20; citation_pages=1747-1763; citation_date=2005; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000664" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis"/>
    <meta name="twitter:description" content="A recent high-density linkage screen confirmed that the HLA complex contains the strongest genetic factor for the risk of multiple sclerosis (MS). In parallel, a linkage disequilibrium analysis using 650 single nucleotide polymorphisms (SNP) markers of the HLA complex mapped the entire genetic effect to the HLA-DR-DQ subregion, reflected by the well-established risk haplotype HLA-DRB1*15,DQB1*06. Contrary to this, in a cohort of 1,084 MS patients and 1,347 controls, we show that the HLA-A gene confers an HLA-DRB1 independent influence on the risk of MS (P&#8202;=&#8202;8.4&times;10&minus;10). This supports the opposing view, that genes in the HLA class I region indeed exert an additional influence on the risk of MS, and confirms that the class I allele HLA-A*02 is negatively associated with the risk of MS (OR&#8202;=&#8202;0.63, P&#8202;=&#8202;7&times;10&minus;12) not explained by linkage disequilibrium with class II. The combination of HLA-A and HLA-DRB1 alleles, as represented by HLA-A*02 and HLA-DRB1*15, was found to influence the risk of MS 23-fold. These findings imply complex autoimmune mechanisms involving both the regulatory and the effector arms of the immune system in the triggering of MS."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0000664.g001"/>

  <meta property="og:title" content="HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000664" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=1900'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=1167'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=6778&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0000664">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000664" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000664&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    <i>HLA-A</i> Confers an <i>HLA-DRB1</i> Independent Influence on the Risk of Multiple Sclerosis
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Boel Brynedal
              <span class="equal-contrib"
                    title="These authors contributed equally to this work">equal contributor</span>
              <span class="corresponding">mail</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">

                <p><span class="equal-contrib" title="These authors contributed equally to this work">equal contributor</span>
                Contributed equally to this work with: Boel Brynedal, Kristina Duvefelt</p>

              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:boel.brynedal@ki.se">boel.brynedal@ki.se</a></p>

                <p>Affiliation:
                  Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Kristina Duvefelt
              <span class="equal-contrib"
                    title="These authors contributed equally to this work">equal contributor</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">

                <p><span class="equal-contrib" title="These authors contributed equally to this work">equal contributor</span>
                Contributed equally to this work with: Boel Brynedal, Kristina Duvefelt</p>

              
              

                <p>Affiliations:
                  Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden, 
                  Mutation Analysis Facility, Clinical Research Center, Karolinska University Hospital, Stockholm, Sweden
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Gudrun Jonasdottir, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Izaura M. Roos, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Eva Åkesson, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Juni Palmgren, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Mutation Analysis Facility, Clinical Research Center, Karolinska University Hospital, Stockholm, Sweden
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Jan Hillert
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: July 25, 2007</li>
    <li>DOI: 10.1371/journal.pone.0000664</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0000664" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0000664" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000664" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0000664" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0000664-t001" data-doi="info:doi/10.1371/journal.pone.0000664" data-uri="info:doi/10.1371/journal.pone.0000664.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000664.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000664-t002" data-doi="info:doi/10.1371/journal.pone.0000664" data-uri="info:doi/10.1371/journal.pone.0000664.t002" title="Table 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000664.t002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000664-t003" data-doi="info:doi/10.1371/journal.pone.0000664" data-uri="info:doi/10.1371/journal.pone.0000664.t003" title="Table 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000664.t003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000664-t004" data-doi="info:doi/10.1371/journal.pone.0000664" data-uri="info:doi/10.1371/journal.pone.0000664.t004" title="Table 4">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000664.t004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000664-g001" data-doi="info:doi/10.1371/journal.pone.0000664" data-uri="info:doi/10.1371/journal.pone.0000664.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000664.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000664">Reader Comments (0)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0000664" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2><a id="article1.front1.article-meta1.abstract1.p1" name="article1.front1.article-meta1.abstract1.p1"></a><p>A recent high-density linkage screen confirmed that the HLA complex contains the strongest genetic factor for the risk of multiple sclerosis (MS). In parallel, a linkage disequilibrium analysis using 650 single nucleotide polymorphisms (SNP) markers of the HLA complex mapped the entire genetic effect to the <em>HLA-DR-DQ</em> subregion, reflected by the well-established risk haplotype <em>HLA-DRB1*15,DQB1*06</em>. Contrary to this, in a cohort of 1,084 MS patients and 1,347 controls, we show that the <em>HLA-A</em> gene confers an <em>HLA-DRB1</em> independent influence on the risk of MS (P = 8.4×10<sup>−10</sup>). This supports the opposing view, that genes in the HLA class I region indeed exert an additional influence on the risk of MS, and confirms that the class I allele <em>HLA-A*02</em> is negatively associated with the risk of MS (OR = 0.63, P = 7×10<sup>−12</sup>) not explained by linkage disequilibrium with class II. The combination of <em>HLA-A</em> and <em>HLA-DRB1</em> alleles, as represented by <em>HLA-A*02</em> and <em>HLA-DRB1*15</em>, was found to influence the risk of MS 23-fold. These findings imply complex autoimmune mechanisms involving both the regulatory and the effector arms of the immune system in the triggering of MS.</p>
</div>


<div class="articleinfo"><p><strong>Citation: </strong>Brynedal B, Duvefelt K, Jonasdottir G, Roos IM, Åkesson E, et al.  (2007) <em>HLA-A</em> Confers an <em>HLA-DRB1</em> Independent Influence on the Risk of Multiple Sclerosis. PLoS ONE 2(7):
          e664.
            doi:10.1371/journal.pone.0000664</p><p><strong>Academic Editor: </strong>Suzanne Leal, Baylor College of Medicine, United States of America</p><p><strong>Received:</strong> May 25, 2007; <strong>Accepted:</strong> June 16, 2007; <strong>Published:</strong> July 25, 2007</p><p><strong>Copyright:</strong> © 2007 Brynedal et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>This study was supported by grants from the Swedish Research Council (project number 11220), the Swedish society of Neurologically Disabled, Bibbi &amp; Nils Jensens Foundation, the Swedish Foundation for Strategic Research and Karolinska Institutet.</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>The human leukocyte antigen (HLA) gene complex on chromosome 6 has been linked to and associated with several supposedly autoimmune diseases. This highly variable region harbors over 420 genes<a href="#pone.0000664-Horton1">[1]</a> and has been unambiguously associated with multiple sclerosis (MS, MIM 126200) susceptibility since 1972<a href="#pone.0000664-Jersild1">[2]</a>. Extensive polymorphism and linkage disequilibrium (LD) complicates the efforts to precisely map associations with MS in this region but most evidence has pointed to the class II region and the <em>HLA-DRB1</em>(GeneID: 3123) and <em>-DQB1</em> genes, and specifically to the haplotype <em>DRB1*1501,DRB5*0101,DQA1*0102,DQB1*0602</em><a href="#pone.0000664-Hillert1">[3]</a>.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>Recently, Lincoln and colleagues reported data on 4,203 individuals from 1,185 Canadian and Finnish MS families genotyped for approximately 650 SNP markers spanning the HLA complex and its flanking regions, in all 13 Mb<a href="#pone.0000664-Lincoln1">[4]</a>. Strong associations were observed with several LD blocks within the HLA class II subregion. Conditioning for <em>HLA-DRB1</em> revealed that all block or SNP associations were dependent on the <em>HLA-DRB1</em> gene, implying that the HLA associated MS susceptibility is determined by HLA class II alleles or closely located variants <a href="#pone.0000664-Lincoln1">[4]</a>. However, this study did not assess any functional gene variants besides <em>HLA-DRB1</em>, such as the <em>HLA-A</em> gene (GeneID: 3105). Also, most likely due to the difficulty of designing assays against SNP markers in highly polymorphic genes, no SNP within or close to <em>HLA-A</em> were genotyped. The original reports on HLA associations with MS were indeed focused on the HLA class I specificities <em>HLA-A</em> and <em>HLA-B</em> <a href="#pone.0000664-Jersild1">[2]</a>, <a href="#pone.0000664-Naito1">[5]</a>. Somewhat later, when class II specificities were discovered and the strong association between <em>HLA-DRB1</em> and MS emerged, the class I associations were regarded as secondary <a href="#pone.0000664-Jersild2">[6]</a>. More recently the possible importance of HLA class I genes in MS susceptibility has been re-investigated by us and others <a href="#pone.0000664-FogdellHahn1">[7]</a>–<a href="#pone.0000664-Yeo1">[9]</a>. Fogdell-Hahn and co-workers examined the role of classical HLA genes including both class I (<em>HLA-A, -B, -C</em>) and class II (<em>HLA-DRB1, -DQ, -DP</em>), indicating that <em>HLA-A*03</em> confers a risk for MS while <em>HLA-A*02</em> has a protective effect <a href="#pone.0000664-FogdellHahn1">[7]</a>. This primary study, as well as that of Harbo and co-workers <a href="#pone.0000664-Harbo1">[8]</a>, was too limited in size to establish a possible independence from the influence of class II alleles due to LD. Further, in addition to the classical association with the <em>HLA-DRB1*15</em>-carrying haplotype, recent studies have identified a more complex situation where several <em>HLA-DRB1</em> alleles interact in determining the risk of MS <a href="#pone.0000664-Dyment1">[10]</a>, <a href="#pone.0000664-Barcellos1">[11]</a>. In the present study, we set out to investigate how alleles of the <em>HLA-DRB1</em> and <em>HLA-A</em> genes interact in determining the risk of MS. In order to distinguish the importance of two multiallelic loci, in addition to a sufficiently large sample size, a statistic strategy needs to be applied where the effect of one allele can be evaluated in the presence of other effects. Here, we use multiple logistic regression models enabling simultaneous analysis of all included alleles while adjusting for the potential confounding effect due to LD <a href="#pone.0000664-Cordell1">[12]</a>. Thus, we were able to establish an <em>HLA-DRB1</em> independent effect of <em>HLA-A</em> in MS susceptibility.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Materials and Methods"></a><h3>Materials and Methods</h3><a id="article1.body1.sec2.p1" name="article1.body1.sec2.p1"></a><p>The 1,084 MS patients included in this study were diagnosed by neurologists at the Karolinska University Hospital and fulfilled the McDonald criteria of MS<a href="#pone.0000664-McDonald1">[13]</a>, their mean age was 51.5 years. The control group consisted of 1,347 consecutively collected blood donors with a mean age of 45.6. The study population was residents of the Stockholm area and predominantly Swedish, including a few percent from other Scandinavian countries but excluding persons with a non-Scandinavian origin. Oral informed consent was obtained from all participants, and the ethical board of Karolinska Institutet approved the study. None of the included patients or controls had been included in our previous study on HLA class I in MS <a href="#pone.0000664-FogdellHahn1">[7]</a>.</p>
<a id="article1.body1.sec2.p2" name="article1.body1.sec2.p2"></a><p>Functional alleles of <em>HLA-A</em> and <em>HLA-DRB1</em> were identified by use of allele specific primers <a href="#pone.0000664-Olerup1">[14]</a> (<a href="#pone-0000664-t001">Table 1</a>). Genotypes carried by individuals utilized as controls were in Hardy Weinberg equilibrium <a href="#pone.0000664-Guo1">[15]</a> for both genes (data not shown). For the logistic regression analysis, we used the methodology proposed by Cordell and Clayton <a href="#pone.0000664-Cordell1">[12]</a> in which nested hypotheses involving logistic regression models of different loci are compared using likelihood ratio tests. The first step was performed to establish which locus had the strongest effect in initial models with single point effects of <em>HLA-A</em> and <em>HLA-DRB1</em>. The following step involved adding loci into the model until the Likelihood-Ratio Test (LRT) was non-significant. In our analysis this meant assessing the additional effect of <em>HLA-A</em> on MS susceptibility over and above the effect of <em>HLA-DRB1</em>. The analysis up to this point included all alleles with a frequency among the MS patients of &gt;5%.</p>
<div class="figure" id="pone-0000664-t001"><div class="img"><a name="pone-0000664-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000664.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000664" data-uri="info:doi/10.1371/journal.pone.0000664.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000664.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000664.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000664.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000664.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000664.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000664.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000664.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000664.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000664.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>Allele frequencies (at a resolution corresponding to serological specificities) of <em>HLA-A</em> and <em>HLA-DRB1</em> in MS patients (n = 1084) and healthy controls (n = 1347).</span></strong></p><span>doi:10.1371/journal.pone.0000664.t001</span></div><a id="article1.body1.sec2.p3" name="article1.body1.sec2.p3"></a><p>To further pinpoint the specific alleles contributing to MS susceptibility, we applied stepwise logistic regression on an allelic level. Starting from a model with all <em>HLA-A</em> and <em>HLA-DRB1</em> alleles, the least significant allele was removed one at the time, until the effect size of all remaining alleles were significant. Finally, the last model comparison assessed whether an interaction between <em>HLA-DRB1</em> and <em>HLA-A</em> would improve the prediction. For a complete description of all the models used in the analysis see Supporting Information <a href="#pone.0000664.s001">Table S1</a>. It should be noted that odds ratios obtained in a logistic regression framework are adjusted for all the other alleles included in the model, and therefore differ from those obtained when a given allele is compared to all other alleles, the most commonly used comparison in previous studies. We declared the odds ratio for a specific allele (relative to the baseline comparators) as statistically significant if the p-value exceeded a Bonferroni corrected threshold. The overall significance level α, chosen to be 0.05, was divided by 11, i.e. the total number of global tests (4) plus the total number of steps in the stepwise allele selection (7).</p>
</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Results and Discussion"></a><h3>Results and Discussion</h3><a id="article1.body1.sec3.p1" name="article1.body1.sec3.p1"></a><p>A model including the main effects of both <em>HLA-A</em> and <em>HLA-DRB1</em> (model 3 in <a href="#pone-0000664-t002">Table 2</a>) predicted the subjects' disease status significantly better than the model including only <em>HLA-DRB1</em> (model 2). The P-value for this comparison was 8×10<sup>−10</sup>, illustrating a strong additional effect of <em>HLA-A</em> on MS susceptibility (<a href="#pone-0000664-t002">Table 2</a>), It should be noted that the P-value refers to the <em>independent</em> effect of <em>HLA-A</em>, since the LD between the two loci is accounted for by including (conditioning on) <em>HLA-DRB1</em> in the logistic regression model.</p>
<div class="figure" id="pone-0000664-t002"><div class="img"><a name="pone-0000664-t002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000664.t002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000664" data-uri="info:doi/10.1371/journal.pone.0000664.t002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000664.t002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000664.t002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000664.t002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000664.t002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000664.t002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000664.t002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000664.t002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000664.t002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000664.t002.TIF"></span>)
                </a></li></ul></div><p><strong>Table 2.  <span>Comparison of the nested logistic regression models of HLA-DRB1 and HLA-A</span></strong></p><span>doi:10.1371/journal.pone.0000664.t002</span></div><a id="article1.body1.sec3.p2" name="article1.body1.sec3.p2"></a><p>In order to pinpoint the alleles that confer an effect on MS susceptibility, a stepwise logistic regression was performed on all the alleles with frequency above 5%. The excluded alleles are reported in Supporting Information <a href="#pone.0000664.s002">Table S2</a>, whereas the alleles in the final model are reported in <a href="#pone-0000664-t003">Table 3</a> along with corresponding statistics. As expected, our results showed that the <em>DRB1*15</em> allele increased the risk of developing MS (OR = 2.9, P&lt;2×10<sup>−16</sup>) (<a href="#pone-0000664-t003">Table 3</a>). The described heterogeneity of effects on MS susceptibility at the <em>HLA-DRB1</em> locus <a href="#pone.0000664-Dyment1">[10]</a>, <a href="#pone.0000664-Barcellos1">[11]</a> was partly confirmed, since several DRB1 alleles show significant association (<a href="#pone-0000664-t003">Table 3</a>). Dyment et al <a href="#pone.0000664-Dyment1">[10]</a> reported an under-transmission of <em>DRB1*01</em> to affected offspring positive for <em>DRB1*15</em>, thus the <em>DRB1*01/DRB1*15</em> genotype would be uncommon among patients with MS. In contrast, we observed a protective effect of <em>HLA-DRB1*01</em> (OR = 0.69 P = 1×10<sup>−3</sup>), independently of <em>HLA-DRB1*15</em>. Similarly, a pool of less common <em>HLA-DRB1</em> alleles (<em>DRB1*07, DRB1*09, DRB1*10, DRB1*11, DRB1*12, DRB1*14, DRB1*16</em> and <em>DRB1*103</em>) was negatively associated with the risk of MS (OR = 0.77, P = 2×10<sup>−3</sup>). This was most likely an effect of one or several of the included alleles. All DRB1X alleles had low frequency and were combined into one entity due to expected lack of power.</p>
<div class="figure" id="pone-0000664-t003"><div class="img"><a name="pone-0000664-t003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000664.t003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000664" data-uri="info:doi/10.1371/journal.pone.0000664.t003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000664.t003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000664.t003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000664.t003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000664.t003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000664.t003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000664.t003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000664.t003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000664.t003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000664.t003.TIF"></span>)
                </a></li></ul></div><p><strong>Table 3.  <span>Alleles of <em>HLA-A</em> and <em>HLA-DRB1</em> significantly associated with the susceptibility to MS identified by backward stepwise logistic regression analysis.</span></strong></p><span>doi:10.1371/journal.pone.0000664.t003</span></div><a id="article1.body1.sec3.p3" name="article1.body1.sec3.p3"></a><p>At the <em>HLA-A</em> locus, the <em>A*02</em> allele decreased the risk of MS (OR = 0.63, P = 7×10<sup>−12</sup>). No other <em>HLA-A</em> allele had an effect that differed significantly from that of the baseline.</p>
<a id="article1.body1.sec3.p4" name="article1.body1.sec3.p4"></a><p>Our results do not confirm an independent role of <em>HLA-A*03</em> in MS susceptibility. In <a href="#pone-0000664-t004">Table 4</a> we have compared our results, using logistic regression, with Fishers exact test and Cochran-Armitage test for trend of genotype distribution in our material. Both unadjusted approaches showed significant p-values for <em>HLA-A*03</em> (3×10<sup>−3</sup> and 7×10<sup>−4</sup> respectively), whereas adjusting for other alleles generated a p-value of 0.95. This may seem contradictory to previous studies <a href="#pone.0000664-FogdellHahn1">[7]</a>, <a href="#pone.0000664-Harbo1">[8]</a>, but in fact shows the strength of the current statistical approach; the <em>A*03</em> association previously detected is presumably a reciprocal effect of the decreased <em>A*02</em> frequency or caused by confounding from the <em>DRB1</em> locus. At the <em>HLA-DRB1</em> locus, <em>DRB1*03, DRB1*04</em> and <em>DRB1*13</em> show significant p-values in the unadjusted analysis, not confirmed by logistic regression, thus most likely a reciprocal effect of the strong <em>DRB1*15</em> association.</p>
<div class="figure" id="pone-0000664-t004"><div class="img"><a name="pone-0000664-t004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000664.t004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000664" data-uri="info:doi/10.1371/journal.pone.0000664.t004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000664.t004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000664.t004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000664.t004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000664.t004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000664.t004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000664.t004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000664.t004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000664.t004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000664.t004.TIF"></span>)
                </a></li></ul></div><p><strong>Table 4.  <span>Comparison of p-values: logistic regression with all alleles of <em>HLA-DRB1</em> and <em>HLA-A</em> included simultaneously vs. Cochran-Armitage Trend tests and Fisher's Exact tests on one allele at the time.</span></strong></p><span>doi:10.1371/journal.pone.0000664.t004</span></div><a id="article1.body1.sec3.p5" name="article1.body1.sec3.p5"></a><p>We proceeded by fitting a model with possible interactions between the <em>HLA-A</em> and <em>HLA-DRB1</em> loci. When comparing the model including interaction terms (model 5) with model 4 we found no improvement in the ability to predict the subjects' disease status (<a href="#pone-0000664-t002">Table 2</a>); the global p-value was 0.98 and none of the included interaction terms were significant. We could therefore conclude that the HLA-A*02 association was independent of the <em>HLA-DRB1</em> locus and specifically the <em>DRB1*15</em> allele; neither LD nor interaction with <em>HLA-DRB1</em> had influenced the association of <em>HLA-A*02</em> with MS. So in contrary to the recent SNP-based LD mapping study <a href="#pone.0000664-Lincoln1">[4]</a>, we clearly show a HLA class I effect independent of <em>HLA-DRB1</em>.</p>
<a id="article1.body1.sec3.p6" name="article1.body1.sec3.p6"></a><p>It has previously been reported that <em>HLA-DRB1*15</em> exerts an allele dose effect on the risk of MS <a href="#pone.0000664-Modin1">[16]</a>, <a href="#pone.0000664-Barcellos2">[17]</a>. <a href="#pone-0000664-g001">Figure 1</a> illustrates how the genotypes of <em>HLA-DRB1</em> and <em>HLA-A</em> jointly modified the empirical OR's of MS, the most susceptible genotypes (homozygosity for <em>DRB1*15</em> but no <em>A*02</em>) and most resistant (homozygosity for <em>A*02</em> but no <em>DRB1*15</em>) genotypes differed 23 fold in the risk of MS. The magnitude of the risk jointly conferred by these loci greatly exceeds the relative risk of 3.5 typically seen for carriage of <em>HLA-DRB1*15</em>. This indicates that genes in the HLA region may confer a larger fraction of the genetic aetiology of MS than previously thought. This notion is further supported by the results of recent MS linkage analyses; in these studies, with increasing power of the analysis, the HLA locus has gradually obtained higher LOD scores, eventually exceeding 11, while all other candidate loci have remained insignificant<a href="#pone.0000664-1">[18]</a>, <a href="#pone.0000664-Sawcer1">[19]</a>. Recently, Yeo and co-workers reported an association with several alleles of <em>HLA-DRB1,</em> together with a negative association with the HLA class I allele <em>HLA-C*05</em> in patients lacking DRB1 risk alleles, a finding which supports the importance of HLA class I genes in MS <a href="#pone.0000664-Yeo1">[9]</a>. However, it remains to be studied whether the <em>HLA-C</em> locus contributes to MS susceptibility in our population, and, if so, whether there may be a confounding effect of LD between <em>HLA-A*02</em> and <em>HLA-C*05.</em></p>
<div class="figure" id="pone-0000664-g001"><div class="img"><a name="pone-0000664-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000664.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000664" data-uri="info:doi/10.1371/journal.pone.0000664.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000664.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000664.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000664.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000664.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000664.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000664.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000664.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000664.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000664.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Empirical odds ratios (ORs) for combinations of the <em>HLA-DRB1*15</em> and <em>HLA-A*02</em> alleles.</span></strong></p><a id="article1.body1.sec3.fig1.caption1.p1" name="article1.body1.sec3.fig1.caption1.p1"></a><p>A genotype of two <em>HLA-A*</em>02 alleles but no <em>HLA-DRB1*15</em> allele was used as baseline in the calculation of ORs. P values are reported above the bars.</p>
<span>doi:10.1371/journal.pone.0000664.g001</span></div><a id="article1.body1.sec3.p7" name="article1.body1.sec3.p7"></a><p>The HLA complex is reputed for strong LD. Therefore, a newly reported genetic association could be expected to be secondary to a previously known association. As explained above, this was clearly not the case for the <em>HLA-A</em> association. The two global measures used (Cramer's V and Kendall's tau-b) showed low levels of LD (0.25 and -0.030 respectively). However weak, an LD of this magnitude could potentially affect allele distributions at the linked locus and induce a secondary association, but in the case of the <em>HLA-A*02</em> allele this possibility is rejected by the results of the logistic regression analysis (P = 8.4×10<sup>−10</sup>). Pairwise LD has been estimated and is reported in Supporting Information <a href="#pone.0000664.s003">Tables S3</a> and <a href="#pone.0000664.s004">S4</a>. While it is principally possible that the <em>HLA-A</em> association in MS is due to another genetic variant in LD with <em>HLA-A*02</em>, data from the HapMap project shows that <em>HLA-A</em> is not part of any sizable LD block.</p>
<a id="article1.body1.sec3.p8" name="article1.body1.sec3.p8"></a><p>Frequencies of HLA alleles are known to vary considerably between different populations, presumably due to genetic drift and different environmental challenges. Therefore a correct random sample of the population is important for the evaluation of HLA associations within that population. We therefore compared the distribution of <em>HLA-A</em> and <em>HLA-DR</em> alleles in our controls to the HLA genotype data available from the Swedish bone marrow registry (n = 40 162 and 11 006 respectively) and found no significant deviation. In particular, the <em>HLA-A*0</em>2 frequencies are highly comparable (allele frequency of 35.9% in our controls compared to 35.3% in the Swedish bone marrow registry). Thus we feel confident that our control group is a suitable random sample of the Swedish population.</p>
<a id="article1.body1.sec3.p9" name="article1.body1.sec3.p9"></a><p>The HLA gene complex is different from other genomic regions by harbouring the most polymorphic genes we know; isotypic and allotypic polymorphism is in fact central to the physiological role of the class I and class II molecules. Therefore, it is not surprising that genetic association studies applying anonymous markers such as microsatellites and SNPs <a href="#pone.0000664-Lincoln1">[4]</a> are less efficient in detecting associations than the functional variants themselves.</p>
<a id="article1.body1.sec3.p10" name="article1.body1.sec3.p10"></a><p>With the present results in mind, it is reasonable to speculate that the genetic risk is indeed influenced by a function of an HLA class I molecule, possibly HLA-A. In contrast to the principle role of HLA-class II molecules in the triggering of an adaptive immune response, HLA class I antigens instead typically interact with cytotoxic CD8+ T cells. In fact, CD8+ T cells outnumber CD4+ T cells in MS lesions and may be of central importance in lesion pathogenesis (reviewed in <a href="#pone.0000664-Friese1">[20]</a>). In addition, HLA class I molecules also interact with NK cells, and are in this way important for innate immunity.</p>
<a id="article1.body1.sec3.p11" name="article1.body1.sec3.p11"></a><p>Further mapping efforts to locate genetic effects on MS susceptibility within this region should preferably employ functional variants along with other markers. In addition, functional studies of HLA class I molecules in MS are motivated.</p>
<a id="article1.body1.sec3.p12" name="article1.body1.sec3.p12"></a><p>To conclude; using a large case control material and simple, straightforward statistical analysis we have shown that <em>HLA-A</em> confers an additional influence on MS susceptibility in the Swedish population, not attributable to the known <em>HLA-DRB1</em> association. This role of HLA class I genes may have important implications for the disease triggering mechanisms in MS.</p>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Supporting Information"></a><h3>Supporting Information</h3><div class="figshare_widget" doi="10.1371/journal.pone.0000664"></div><a name="pone.0000664.s001" id="pone.0000664.s001"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000664.s001">Table S1. </a></strong></p><a id="article1.body1.sec4.supplementary-material1.caption1.p1" name="article1.body1.sec4.supplementary-material1.caption1.p1"></a><p class="preSiDOI">Model description.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000664.s001</p><a id="article1.body1.sec4.supplementary-material1.caption1.p2" name="article1.body1.sec4.supplementary-material1.caption1.p2"></a><p class="postSiDOI">(0.03 MB DOC)</p>
<a name="pone.0000664.s002" id="pone.0000664.s002"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000664.s002">Table S2. </a></strong></p><a id="article1.body1.sec4.supplementary-material2.caption1.p1" name="article1.body1.sec4.supplementary-material2.caption1.p1"></a><p class="preSiDOI">Sequential exclusion of alleles in the stepwise logistic regression procedure. At each step, the least significant allele was removed until all remaining alleles in the model were significant (<a href="#pone-0000664-t003">Table 3</a>) at α  = 0.05/11.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000664.s002</p><a id="article1.body1.sec4.supplementary-material2.caption1.p2" name="article1.body1.sec4.supplementary-material2.caption1.p2"></a><p class="postSiDOI">(0.03 MB DOC)</p>
<a name="pone.0000664.s003" id="pone.0000664.s003"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000664.s003">Table S3. </a></strong></p><a id="article1.body1.sec4.supplementary-material3.caption1.p1" name="article1.body1.sec4.supplementary-material3.caption1.p1"></a><p class="preSiDOI">Pair-wise LD measures, D' and R2, and two global (multi-allelic) measures of LD: Cramer's V and Kendall's tau-b for alleles of HLA-A and HLA-DRB1 among controls.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000664.s003</p><a id="article1.body1.sec4.supplementary-material3.caption1.p2" name="article1.body1.sec4.supplementary-material3.caption1.p2"></a><p class="postSiDOI">(0.05 MB DOC)</p>
<a name="pone.0000664.s004" id="pone.0000664.s004"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000664.s004">Table S4. </a></strong></p><a id="article1.body1.sec4.supplementary-material4.caption1.p1" name="article1.body1.sec4.supplementary-material4.caption1.p1"></a><p class="preSiDOI">Pair-wise LD measures, D' and R2, and two global (multi-allelic) measures of LD: Cramer's V and Kendall's tau-b for alleles of HLA-A and HLA-DRB1 among cases.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000664.s004</p><a id="article1.body1.sec4.supplementary-material4.caption1.p2" name="article1.body1.sec4.supplementary-material4.caption1.p2"></a><p class="postSiDOI">(0.05 MB DOC)</p>
</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>H. Cordell is acknowledged for valuable comments on logistic regression and LD. O. Olerup is acknowledged for useful assistance. We thank all the patients and volunteers that participated in this study. The local ethics committee of the Karolinska Institutet approved the study. All participants gave their informed consent.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: KD JH. Performed the experiments: BB. Analyzed the data: GJ. Wrote the paper: BB KD. Other: Contributed with reagents and samples: JH. Revised the manuscript: GJ JH EA IR KD BB. Contributed to the analysis of data: JP. Wrote the statistical sections in the manuscript: GJ JP. Collected samples and evaluated the patients: EA. Contributed to genotyping: IR. Contributed to the statistical design: GJ KD BB.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0000664-Horton1" id="pone.0000664-Horton1"></a>Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, et al.  (2004) Gene map of the extended human MHC. Nat Rev Genet  5: 889–899.  <ul class="find" data-citedArticleID="970672" data-doi="10.1038/nrg1489"><li><a href="http://dx.doi.org/10.1038/nrg1489" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Gene+map+of+the+extended+human+MHC." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Gene+map+of+the+extended+human+MHC.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0000664-Jersild1" id="pone.0000664-Jersild1"></a>Jersild C, Fog T (1972) Histocompatibility (HL-A) antigens associated with multiple sclerosis. Acta Neurol Scand Suppl  51: 377.  <ul class="find" data-citedArticleID="970674"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Histocompatibility+%28HL-A%29+antigens+associated+with+multiple+sclerosis.&amp;auth=&amp;atitle=Histocompatibility+%28HL-A%29+antigens+associated+with+multiple+sclerosis." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Histocompatibility+%28HL-A%29+antigens+associated+with+multiple+sclerosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Histocompatibility+%28HL-A%29+antigens+associated+with+multiple+sclerosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0000664-Hillert1" id="pone.0000664-Hillert1"></a>Hillert J (1994) Human leukocyte antigen studies in multiple sclerosis. Ann Neurol 36 SupplS15–17.  <ul class="find" data-citedArticleID="970670" data-doi="10.1002/ana.410360706"><li><a href="http://dx.doi.org/10.1002/ana.410360706" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Human+leukocyte+antigen+studies+in+multiple+sclerosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Human+leukocyte+antigen+studies+in+multiple+sclerosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0000664-Lincoln1" id="pone.0000664-Lincoln1"></a>Lincoln MR, Montpetit A, Cader MZ, Saarela J, Dyment DA, et al.  (2005) A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet  37: 1108–1112.  <ul class="find" data-citedArticleID="970678" data-doi="10.1038/ng1647"><li><a href="http://dx.doi.org/10.1038/ng1647" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+predominant+role+for+the+HLA+class+II+region+in+the+association+of+the+MHC+region+with+multiple+sclerosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+predominant+role+for+the+HLA+class+II+region+in+the+association+of+the+MHC+region+with+multiple+sclerosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0000664-Naito1" id="pone.0000664-Naito1"></a>Naito S, Namerow N, Mickey MR, Terasaki PI (1972) Multiple sclerosis: association with HL-A3. Tissue Antigens  2: 1–4.  <ul class="find" data-citedArticleID="970684" data-doi="10.1111/j.1399-0039.1972.tb00111.x"><li><a href="http://dx.doi.org/10.1111/j.1399-0039.1972.tb00111.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Multiple+sclerosis%3A+association+with+HL-A3." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Multiple+sclerosis%3A+association+with+HL-A3.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0000664-Jersild2" id="pone.0000664-Jersild2"></a>Jersild C, Fog T, Hansen GS, Thomsen M, Svejgaard A, et al.  (1973) Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet  2: 1221–1225.  <ul class="find" data-citedArticleID="970676" data-doi="10.1016/s0140-6736(73)90970-7"><li><a href="http://dx.doi.org/10.1016/s0140-6736(73)90970-7" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Histocompatibility+determinants+in+multiple+sclerosis%2C+with+special+reference+to+clinical+course." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Histocompatibility+determinants+in+multiple+sclerosis%2C+with+special+reference+to+clinical+course.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0000664-FogdellHahn1" id="pone.0000664-FogdellHahn1"></a>Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O (2000) Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens  55: 140–148.  <ul class="find" data-citedArticleID="970662" data-doi="10.1034/j.1399-0039.2000.550205.x"><li><a href="http://dx.doi.org/10.1034/j.1399-0039.2000.550205.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Multiple+sclerosis%3A+a+modifying+influence+of+HLA+class+I+genes+in+an+HLA+class+II+associated+autoimmune+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Multiple+sclerosis%3A+a+modifying+influence+of+HLA+class+I+genes+in+an+HLA+class+II+associated+autoimmune+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0000664-Harbo1" id="pone.0000664-Harbo1"></a>Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, et al.  (2004) Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens  63: 237–247.  <ul class="find" data-citedArticleID="970668" data-doi="10.1111/j.0001-2815.2004.00173.x"><li><a href="http://dx.doi.org/10.1111/j.0001-2815.2004.00173.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Genes+in+the+HLA+class+I+region+may+contribute+to+the+HLA+class+II-associated+genetic+susceptibility+to+multiple+sclerosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Genes+in+the+HLA+class+I+region+may+contribute+to+the+HLA+class+II-associated+genetic+susceptibility+to+multiple+sclerosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0000664-Yeo1" id="pone.0000664-Yeo1"></a>Yeo TW, De Jager PL, Gregory SG, Barcellos LF, Walton A, et al.  (2007) A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann Neurol.   <ul class="find" data-citedArticleID="970690" data-doi="10.1002/ana.21063"><li><a href="http://dx.doi.org/10.1002/ana.21063" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+second+major+histocompatibility+complex+susceptibility+locus+for+multiple+sclerosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+second+major+histocompatibility+complex+susceptibility+locus+for+multiple+sclerosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0000664-Dyment1" id="pone.0000664-Dyment1"></a>Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, et al.  (2005) Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet  14: 2019–2026.  <ul class="find" data-citedArticleID="970660" data-doi="10.1093/hmg/ddi206"><li><a href="http://dx.doi.org/10.1093/hmg/ddi206" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Complex+interactions+among+MHC+haplotypes+in+multiple+sclerosis%3A+susceptibility+and+resistance." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Complex+interactions+among+MHC+haplotypes+in+multiple+sclerosis%3A+susceptibility+and+resistance.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0000664-Barcellos1" id="pone.0000664-Barcellos1"></a>Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, et al.  (2006) Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet  15: 2813–2824.  <ul class="find" data-citedArticleID="970654" data-doi="10.1093/hmg/ddl223"><li><a href="http://dx.doi.org/10.1093/hmg/ddl223" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Heterogeneity+at+the+HLA-DRB1+locus+and+risk+for+multiple+sclerosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Heterogeneity+at+the+HLA-DRB1+locus+and+risk+for+multiple+sclerosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0000664-Cordell1" id="pone.0000664-Cordell1"></a>Cordell HJ, Clayton DG (2002) A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet  70: 124–141.  <ul class="find" data-citedArticleID="970658" data-doi="10.1086/338007"><li><a href="http://dx.doi.org/10.1086/338007" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+unified+stepwise+regression+procedure+for+evaluating+the+relative+effects+of+polymorphisms+within+a+gene+using+case%2Fcontrol+or+family+data%3A+application+to+HLA+in+type+1+diabetes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+unified+stepwise+regression+procedure+for+evaluating+the+relative+effects+of+polymorphisms+within+a+gene+using+case%2Fcontrol+or+family+data%3A+application+to+HLA+in+type+1+diabetes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0000664-McDonald1" id="pone.0000664-McDonald1"></a>McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al.  (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol  50: 121–127.  <ul class="find" data-citedArticleID="970680" data-doi="10.1002/ana.1032"><li><a href="http://dx.doi.org/10.1002/ana.1032" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Recommended+diagnostic+criteria+for+multiple+sclerosis%3A+guidelines+from+the+International+Panel+on+the+diagnosis+of+multiple+sclerosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Recommended+diagnostic+criteria+for+multiple+sclerosis%3A+guidelines+from+the+International+Panel+on+the+diagnosis+of+multiple+sclerosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0000664-Olerup1" id="pone.0000664-Olerup1"></a>Olerup O, Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens  39: 225–235.  <ul class="find" data-citedArticleID="970686" data-doi="10.1111/j.1399-0039.1992.tb01940.x"><li><a href="http://dx.doi.org/10.1111/j.1399-0039.1992.tb01940.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=HLA-DR+typing+by+PCR+amplification+with+sequence-specific+primers+%28PCR-SSP%29+in+2+hours%3A+an+alternative+to+serological+DR+typing+in+clinical+practice+including+donor-recipient+matching+in+cadaveric+transplantation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22HLA-DR+typing+by+PCR+amplification+with+sequence-specific+primers+%28PCR-SSP%29+in+2+hours%3A+an+alternative+to+serological+DR+typing+in+clinical+practice+including+donor-recipient+matching+in+cadaveric+transplantation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0000664-Guo1" id="pone.0000664-Guo1"></a>Guo SW, Thompson EA (1992) Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics  48: 361–372.  <ul class="find" data-citedArticleID="970666" data-doi="10.2307/2532296"><li><a href="http://dx.doi.org/10.2307/2532296" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Performing+the+exact+test+of+Hardy-Weinberg+proportion+for+multiple+alleles." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Performing+the+exact+test+of+Hardy-Weinberg+proportion+for+multiple+alleles.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0000664-Modin1" id="pone.0000664-Modin1"></a>Modin H, Olsson W, Hillert J, Masterman T (2004) Modes of action of HLA-DR susceptibility specificities in multiple sclerosis. Am J Hum Genet  74: 1321–1322.  <ul class="find" data-citedArticleID="970682" data-doi="10.1086/420977"><li><a href="http://dx.doi.org/10.1086/420977" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Modes+of+action+of+HLA-DR+susceptibility+specificities+in+multiple+sclerosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Modes+of+action+of+HLA-DR+susceptibility+specificities+in+multiple+sclerosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0000664-Barcellos2" id="pone.0000664-Barcellos2"></a>Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, et al.  (2003) HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet  72: 710–716.  <ul class="find" data-citedArticleID="970656" data-doi="10.1086/367781"><li><a href="http://dx.doi.org/10.1086/367781" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=HLA-DR2+dose+effect+on+susceptibility+to+multiple+sclerosis+and+influence+on+disease+course." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22HLA-DR2+dose+effect+on+susceptibility+to+multiple+sclerosis+and+influence+on+disease+course.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0000664-1" id="pone.0000664-1"></a> (2003) A meta-analysis of whole genome linkage screens in multiple sclerosis. J Neuroimmunol  143: 39–46.  <ul class="find" data-citedArticleID="970652" data-doi="10.1016/j.jneuroim.2003.08.009"><li><a href="http://dx.doi.org/10.1016/j.jneuroim.2003.08.009" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+meta-analysis+of+whole+genome+linkage+screens+in+multiple+sclerosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+meta-analysis+of+whole+genome+linkage+screens+in+multiple+sclerosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0000664-Sawcer1" id="pone.0000664-Sawcer1"></a>Sawcer S, Ban M, Maranian M, Yeo TW, Compston A, et al.  (2005) A high-density screen for linkage in multiple sclerosis. Am J Hum Genet  77: 454–467.  <ul class="find" data-citedArticleID="970688" data-doi="10.1038/sj.ejhg.5201457"><li><a href="http://dx.doi.org/10.1038/sj.ejhg.5201457" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+high-density+screen+for+linkage+in+multiple+sclerosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+high-density+screen+for+linkage+in+multiple+sclerosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0000664-Friese1" id="pone.0000664-Friese1"></a>Friese MA, Fugger L (2005) Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain  128: 1747–1763.  <ul class="find" data-citedArticleID="970664" data-doi="10.1093/brain/awh578"><li><a href="http://dx.doi.org/10.1093/brain/awh578" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Autoreactive+CD8%2B+T+cells+in+multiple+sclerosis%3A+a+new+target+for+therapy%3F" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Autoreactive+CD8%2B+T+cells+in+multiple+sclerosis%3A+a+new+target+for+therapy%3F%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.XML" value="63321"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.PDF" value="126154"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t001.PNG_L" value="110800"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t001.PNG_M" value="128136"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t001.PNG_S" value="17285"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t001.TIF" value="539434"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t001.PNG_I" value="52007"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t002.PNG_L" value="158072"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t002.PNG_M" value="88659"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t002.PNG_S" value="10661"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t002.TIF" value="658580"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t002.PNG_I" value="27021"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t003.PNG_L" value="36084"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t003.PNG_M" value="44634"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t003.PNG_S" value="9601"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t003.TIF" value="165816"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t003.PNG_I" value="14574"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t004.PNG_L" value="117361"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t004.PNG_M" value="156366"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t004.PNG_S" value="19887"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t004.TIF" value="521844"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.t004.PNG_I" value="53618"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.g001.PNG_L" value="19862"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.g001.PNG_M" value="45581"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.g001.PNG_S" value="6867"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.g001.TIF" value="31148"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.g001.PNG_I" value="16266"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.s001.DOC" value="30720"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.s002.DOC" value="31232"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.s003.DOC" value="47104"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000664.s004.DOC" value="46080"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000664&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000664" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000664&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0000664&volume=&issue=&title=HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis&author_name=Boel%20Brynedal%2C%20Kristina%20Duvefelt%2C%20Gudrun%20Jonasdottir%2C%20Izaura%20M.%20Roos%2C%20Eva%20%C3%85kesson%2C%20Juni%20Palmgren%2C%20Jan%20Hillert&start_page=1&end_page=5" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000664" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000664" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0000664" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000664&amp;t=HLA-A%20Confers%20an%20HLA-DRB1%20Independent%20Influence%20on%20the%20Risk%20of%20Multiple%20Sclerosis" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000664&title=HLA-A%20Confers%20an%20HLA-DRB1%20Independent%20Influence%20on%20the%20Risk%20of%20Multiple%20Sclerosis&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000664&amp;title=HLA-A%20Confers%20an%20HLA-DRB1%20Independent%20Influence%20on%20the%20Risk%20of%20Multiple%20Sclerosis" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000664" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0000664&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0000664';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20HLA-A%20Confers%20an%20HLA-DRB1%20Independent%20Influence%20on%20the%20Risk%20of%20Multiple%20Sclerosis http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000664" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0000664" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">


















          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Alleles%22" title="Search for articles in the subject area:'Alleles'"><div class="flagText">Alleles</div></a>
              <div data-categoryid="46071" data-articleid="24166"
                   data-categoryname="Alleles"
                   class="flagImage" title="Flag 'Alleles' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Gene+mapping%22" title="Search for articles in the subject area:'Gene mapping'"><div class="flagText">Gene mapping</div></a>
              <div data-categoryid="47615" data-articleid="24166"
                   data-categoryname="Gene mapping"
                   class="flagImage" title="Flag 'Gene mapping' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Genetic+loci%22" title="Search for articles in the subject area:'Genetic loci'"><div class="flagText">Genetic loci</div></a>
              <div data-categoryid="17713" data-articleid="24166"
                   data-categoryname="Genetic loci"
                   class="flagImage" title="Flag 'Genetic loci' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Haplotypes%22" title="Search for articles in the subject area:'Haplotypes'"><div class="flagText">Haplotypes</div></a>
              <div data-categoryid="19681" data-articleid="24166"
                   data-categoryname="Haplotypes"
                   class="flagImage" title="Flag 'Haplotypes' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Linkage+disequilibrium%22" title="Search for articles in the subject area:'Linkage disequilibrium'"><div class="flagText">Linkage disequilibrium</div></a>
              <div data-categoryid="42897" data-articleid="24166"
                   data-categoryname="Linkage disequilibrium"
                   class="flagImage" title="Flag 'Linkage disequilibrium' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Multiple+sclerosis%22" title="Search for articles in the subject area:'Multiple sclerosis'"><div class="flagText">Multiple sclerosis</div></a>
              <div data-categoryid="33571" data-articleid="24166"
                   data-categoryname="Multiple sclerosis"
                   class="flagImage" title="Flag 'Multiple sclerosis' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22T+cells%22" title="Search for articles in the subject area:'T cells'"><div class="flagText">T cells</div></a>
              <div data-categoryid="40147" data-articleid="24166"
                   data-categoryname="T cells"
                   class="flagImage" title="Flag 'T cells' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Variant+genotypes%22" title="Search for articles in the subject area:'Variant genotypes'"><div class="flagText">Variant genotypes</div></a>
              <div data-categoryid="40547" data-articleid="24166"
                   data-categoryname="Variant genotypes"
                   class="flagImage" title="Flag 'Variant genotypes' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=3541'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=6438'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=8940&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>


</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
